Consistent with the observation that inhibiting CXCL10 suppresses the development of steatohepatitis in mice, the results reveal that CXCL10 is implicated in steatosis via up-regulation of SREBP1c and liver X-activated receptor (LXR) (116). The gene discussed is CXCL10; the disease is steatosis.